• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Quotient Sciences

    Federal Equipment Company

    AMERIPHARMA

    CMC Pharmaceuticals

    Lannett CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    Federal Equipment Company

    AMERIPHARMA

    CMC Pharmaceuticals

    Lannett CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Blog

    Pharmacovigilance Market to Grow Significantly via Contract Outsourcing

    The crucial need to monitor the efficiency and after effects of drugs will drive pharmacovigilance market

    Pharmacovigilance Market to Grow Significantly via Contract Outsourcing
    Global Market Insights02.16.18
    The field of pharmacovigilance globally represents the picture of drug effectiveness, safety, and associated risk detection. It is expected that even life science manufacturers will become more proactive due to adoption of pharmacovigilance services, which will stimulate the industry trends. Implementation of stringent rules and regulations regarding clinical trial management and drugs safety will also influence pharmacovigilance industry size. According to the report by Global Market Insights, Inc., the worldwide pharmacovigilance market having had a revenue of $3 billion in 2015, is predicted to surpass a revenue collection of $8 billion by 2024.

    Most of the pharmaceutical and biotechnology firms are adopting these services to maintain and manage clinical trial data, which will favorably influence pharmacovigilance market share from in-house companies, which generated a revenue of $1.5 billion in 2015 and is likely to increase two-fold by 2024.

    Companies established in the developed countries often outsource these services, considering the operational cost reduction effectiveness and quality. The notable business participants in pharmacovigilance market are Accenture, Boehringer Ingelheim, Covance, PAREXEL, Bristol-Myers Squibb, Quintiles, Cognizant Technology Solutions Corporation, United BioSource, and ICON. Contract outsourcing covered more than 50% of the revenue share of the service provider segment in pharmacovigilance industry in 2015 and will exceed a revenue collection of $4.8 billion by 2024. The growing adoption of this segment by the various pharmaceutical firms will stimulate the product demand noticeably.

    Asia Pacific pharmacovigilance market having had a revenue of $835 million in 2015, will surpass a revenue collection of $2.4 billion by 2024. The attributing factors toward the market growth are stringent regulations regarding health, rise in number of clinical trials, and a massive patient base. The region will witness a surge in the number of pre-clinical trials, subject to which pharmacovigilance market from pre-clinical trials will generate a revenue of more than $84 million by 2024 with an annual growth rate of 10.3% over the years ahead.

    U.S. pharmacovigilance industry collected a revenue of $1 billion in 2015 and will exceed a revenue generation of $2.5 billion by 2024 with an annual growth rate of 10.7% over the period of 2016 to 2024. Surging need to monitor the significant effects of medical drugs owing to the increasing mortality rate subject to adverse drug effects will stimulate the product demand. Moreover, rising concern among patients regarding the effectiveness and safety of drugs is predicted to boost pharmacovigilance market size. The need to evaluate drug efficiency based on risk benefit ratio will fuel pharmacovigilance market from phase III clinical trials, which will collect a revenue of more than $1,254 million by 2024, having been valued over $492 million in 2015. Europe pharmacovigilance market will collect a revenue of $1.8 billion by 2024 with a CAGR of 9.9% over the coming seven years. The growth can be attributed to the escalating requirement of personalized medicines. Germany, Spain, and UK covered more than 70% of the Europe regional revenue share in 2015.

    Industry giants are engaged in strategic partnerships with research organizations to enhance the effectiveness of the product. Mergers and acquisitions is a major growth strategy adopted by the market players to comply with competitiveness of the business.
    Related Searches
    • Phase III
    • it
    • Outsourcing
    • bristol-myers squibb
    Suggested For You
    Boehringer Ingelheim Misses Study Endpoints Boehringer Ingelheim Misses Study Endpoints
    Cryoport Teams Up with TiGenix Cryoport Teams Up with TiGenix
    Boehringer Ingelheim U.S. CEO to Retire Boehringer Ingelheim U.S. CEO to Retire
    Prime Therapeutics & Boehringer Ingelheim Enter Collaboration Prime Therapeutics & Boehringer Ingelheim Enter Collaboration
    Marken Opens Third Germany Branch Marken Opens Third Germany Branch
    Massive Growth for the Biotechnology Market by 2024 Massive Growth for the Biotechnology Market by 2024
    Paragon International Becomes Paragon Global CRS Paragon International Becomes Paragon Global CRS
    VIDEO: Almac Expands Clinical and Commercial Drug Supplies Services VIDEO: Almac Expands Clinical and Commercial Drug Supplies Services
    BeiGene, Boehringer Ingelheim Enter Supply Agreement BeiGene, Boehringer Ingelheim Enter Supply Agreement
    Alder BioPharma Alder BioPharma's Eptinezumab Meets Primary Endpoint
    Boehringer Ingelheim and Autifony Enter Agreement Boehringer Ingelheim and Autifony Enter Agreement
    Motif Bio Phase 3 Study Results Published Motif Bio Phase 3 Study Results Published
    Mustang Bio Mustang Bio's CAR T Therapy Achieves Complete Response
    Five Digital Trends Transforming the Life Sciences Industry Five Digital Trends Transforming the Life Sciences Industry
    HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration HitGen, Boehringer Ingelheim Enter Drug Discovery Collaboration

    Related Breaking News

    • Bio News | Breaking News | Clinical Trials | Drug Development | Drug Discovery | Industry News | Laboratory Testing
      Boehringer Ingelheim Misses Study Endpoints

      Boehringer Ingelheim Misses Study Endpoints

      In their Phase II Alzheimer's disease trials with investigational compound BI 409306
      02.09.18

    • Breaking News | Cold Chain Management | Industry News | Logistics | Packaging & Tracking
      Cryoport Teams Up with TiGenix

      Cryoport Teams Up with TiGenix

      Will provide cold chain logistics for clinical trial of SEPCELL for the treatment of sepsis
      02.09.18

    • Industry News | Promotions & Moves
      Boehringer Ingelheim U.S. CEO to Retire

      Boehringer Ingelheim U.S. CEO to Retire

      Paul Fonteyne's last day will be December 31, 2018 after 15 years with the company
      02.01.18


    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News | Methods Development
      Prime Therapeutics & Boehringer Ingelheim Enter Collaboration

      Prime Therapeutics & Boehringer Ingelheim Enter Collaboration

      For diabetes as part of Prime's CareCentered Contracting program
      02.01.18

    • cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News | Packaging & Tracking | Promotions & Moves
      Marken Opens Third Germany Branch

      Marken Opens Third Germany Branch

      The new Stuttgart location joins Marken's existing German locations in Frankfurt and Hamburg
      01.26.18

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    • Merck KGaA, Quris-AI Expand Collaboration
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    Sanner Group Opens Second Manufacturing Facility in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    The Estée Lauder Companies Launches 2023 Breast Cancer Campaign
    BASF Personal Care Introduces New Cosmetic Ingredient
    Breakfast with Oral Care Benefits?
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login